NEXGEN LEGACY LPS ARTICULAR SURFACE
Report
- Report Number
- 1822565-2011-01010
- Event Type
- Injury
- Date Received
- April 21, 2011
- Date of Event
- March 23, 2011
- Report Date
- March 25, 2011
- Manufacturer
- ZIMMER, INC.
- Product Code
- JWH
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- PHYSICIAN
Narratives
EVALUATION SUMMARY: THE X-RAYS AND SURGICAL NOTES ARE NOT AVAILABLE TO ANALYZE THE FIXATION. THE PRODUCTS USED FOR IMPLANTATION ALONG WITH THE LPS ART SURFACE ARE UNK TO CHECK THE COMBINATION. THE COMPLAINT REPORT MENTIONS THAT POST EXPLANATION, SURGEON OBSERVED FRACTURED SPINE OF THE ART SURFACE. THE FRACTURED SPINE COULD BE A CAUSE FOR THE PT'S INSTABILITY. HOWEVER, THE REASON FOR SPINE FRACTURE IS UNK. SPINE FRACTURE COULD OCCUR DUE TO IMPROPER/HIGH LOADS PARTICULARLY WITH EXTERNAL/INTERNAL ROTATION OF THE KNEE. THE FRACTURE IN THE ART SURFACE COULD ALSO BE DUE TO PT'S INJURY/NON-COMPLIANCE BUT CANNOT BE CONFIRMED WITH THE AVAILABLE INFORMATION. REVIEW OF THE DEVICE HISTORY RECORDS DID NOT FIND ANY DEVIATIONS OR ANOMALIES. IT IS NOT SUSPECTED THAT THE PRODUCT FAILED TO MEET SPECIFICATIONS. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY EVIDENCE OF PRODUCT CONTRIBUTION TO THE REPORTED PROBLEM. BASED ON THE AVAILABLE INFORMATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. SHOULD ADDITIONAL SUBSTANTIVE INFORMATION BE REC'D, THE COMPLAINT WILL BE REOPENED. ZIMMER, INC CONSIDERS THE INVESTIGATION CLOSED.
IT IS REPORTED THAT THE PT PRESENTED WITH AN UNSTABLE KNEE. AFTER REVIEW OF THE FEMORAL AND TIBIAL COMPONENTS, THE SURGEON DECIDED TO ONLY EXCHANGE THE ARTICULAR SURFACE. UPON REMOVAL, IT WAS DETERMINED THAT THE PROBABLE CAUSE OF INSTABILITY WAS DUE TO THE SPINE OF THE ARTICULAR SURFACE HAVING FRACTURED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | NEXGEN LEGACY LPS ARTICULAR SURFACE | JWH | ZIMMER, INC. | 68455200 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | Required Intervention |